Matteo Droghetti (@drMDrog) header
Matteo Droghetti (@drMDrog) profile picture

Urologist at IRCCS Azienda-Ospedaliero Universitaria di Bologna | SIU research Office - RWD section | PhD @unibo | Former ccERUS Clinical Fellow @NKI_nl

Bologna, Emilia Romagna
Joined August 2022
Photo by Matteo Droghetti (@drMDrog)Photo by Matteo Droghetti (@drMDrog)Photo by Matteo Droghetti (@drMDrog)Photo by Matteo Droghetti (@drMDrog)
Read European Urology Oncology's latest article published online, by Lorenzo Bianchi et al. Thank you for your contribution! Prostate-specific Membrane Antigen Positron Emission Tomography Versus Conventional Imaging for Preoperative Staging High-risk Prostate Cancer Patients Undergoing Surgery for cN0M0 Disease: An European Association of Urology—Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study Explore the full study at: euoncology.europeanurology.c… @Lorenzo26232839 @drMDrog @cal_Catanzaro @MRoupret @CaPsurvivorshop @Ric_Campi @jteoh_hk @UroDocAsh @Uroweb @F_Montorsi @Albert0Briganti @ClaudiaKesch @roodvdb @riccardosciav6 @dr_rajwa #UroOncology #ProstateCancer #MensHealth #eau #YAU #urologist
3
6
619
Urology of Bologna involved in intensive presentations at EAU25 #Madrid @Uroweb @Unibo
1
3
16
749
How important is knowledge of anatomy for the surgeons of the next gen? learn with the brightest young urologists and anatomists at the university of bologna @Eugenio74446325 @aleantonellibs1 @minerviniandre @agalfano @pietropiazza @paolo_delloglio @GGandaglia @RicBertolo @andreamari08 @AngeloMottaran @drMDrog
2
9
23
999
Catching up some reading & good to see initial conclusions confirmed in longer term results, that adj RT after RP doesn’t improve FFDM or OS & ⬆️ toxicity compared to salvage. There is slight curve sep at 10 years for FFDM with p = 0.09 but seems unlikely to become clinically relevant. secure.jbs.elsevierhealth.co…
7
1
16
4,878
imagination goes beyond reality
1
9
322
Best abstract at EMUC23 EASY-1 project at @Unibo: with intensive surveillance almost 90% of high risk PCa can avoid aRT at 3 years! Congratulations to @drMDrog
1
11
632
1st Edition of the Italian #ESUBootCamp - It's a wrap! A big thank you to all the trainees, the faculty, @UrowebESU @SIU_Italia @HUNIMED for making this a fantastic opportunity for young urology residents to gain hands-on training. #UrologyTraining @NBuffi @tiago_urology
9
32
1,919
Matteo Droghetti retweeted
🔍 New study sheds light on prostate cancer treatment outcomes! 🤔While biochemical recurrence is more common post-radical prostatectomy, the mortality risk is higher post-radiotherapy. 🩺 Rethinking our approach to BCR is crucial to optimize patient care and reduce overtreatment. 🚫 #prostatecancer #ProstateCancerAwarenessMonth @JAMANetworkOpen @OncoAlert @APCCC_Lugano @PCFnews @Tilki_De @piet_ost @AlbertoBossial @GGiannarini @Uromigos @urotoday @Uroweb @zklaassen_md @amerseburger doi:10.1001/jamanetworkopen.2023.32900
6
20
6
74
39,502
Matteo Droghetti retweeted
“It’s unethical to prescribe ADT alone for metastatic prostate cancer”. Strong words from Urologist Prof Fred Saad on latest GU Cast. Also, “urologists shouldn’t dabble in metastatic prostate cancer”. Don’t be a dabbler! – at Melbourne, Victoria
Urologists take note! ARPIs getting reimbursed for mHSPC. GU Cast is back with with Fred Saad, @ciaraconduit @RenuEapen @declangmurphy youtu.be/xNl2JIQN82k
6
11
48
13,487
In well selected patients - solitary tumors < 7 cm, no or unilateral hydronephrosis, minimal CIS - results with TMT are comparable to Radical Cystectomy #patientchoice #bladdercancer #BladderCancerMonth23 thelancet.com/journals/lanon… @TheLancetOncol @BladderCancerUS
7
160
11
399
122,349
#ENZAMET ✅ Trial design and contemporaneous cohorts explained ✅ OS triplet findings for de novo mHSPC align with #PEACE1 & #ARASENS ✅ Proposed treatment plans by prognostic group   Lancet Onc pub & appendix: downloads here ✅https://nitter.cf/t.co/3wjU2IDg1d ✅ https://nitter.cf/t.co/UceOs0Gfyq
1
12
22
3,097
New article (Vol. 183) Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients Marcin Miszczyk et al. doi.org/10.1016/j.radonc.202…
3
24
3
74
9,392
Opinion: Open Science Sentinel Lymph Node Biopsy: A Great Opportunity for Personalized Radiotherapy in Prostate Cancer buff.ly/3K8qKdT @stephane_supiot #prostatecancer
3
4
1,229
Matteo Droghetti retweeted
The last day of recruitment for STAMPEDE today - huge thanks to almost 12000 patients and over 5000 researchers. Thread below summarises some of the contributions we have made. It’s been a huge honour and privilege to lead this.
Our last cancer trial before #WorldCancerDay is STAMPEDE! The #STAMPEDEtrial has been assessing multiple different treatment options for people with advanced or metastatic #ProstateCancer since 2005. Its findings have improved the standard of care for advanced cancer🧵
23
56
15
315
63,406
Intermediate-risk Prostate Cancer—A Sheep in Wolf’s Clothing? buff.ly/38128B0 @Freddie_Hamdy @MRoupret #ESOU #MedTwitter #UroSoMe
3
5
2,123
Matteo Droghetti retweeted
The ARTA mono being superior to ADT is something I would never expect. Opens opportunities in high risk localized PCa and de novo mHSPC.
3
5
2
33
6,378
EMBARK study exploring enzalutamide+ADT vs ADT/placebo vs enza mono in nmCS #ProstateCancer and high-risk BCR met the primary endpoint MFS. Sign. difference also between Enza mono vs ADT/. Curious to see OS, subsequent treatment, PRO data @SFreedlandMD @nealshore @marty_gleave
11
29
3,568
Matteo Droghetti retweeted
PSMA-PET for recurrent #ProstateCancer and guidance of salvage treatments: Is the sooner always the better? (“Shoot Blind” or “Sharpshooting”?). Presentation by @drMDrog @AlleConCancro. #EAU23 written coverage by @rksayyid @UofTUrology > https://nitter.cf/t.co/ksGwqdEFCa @Uroweb
2
1
5
1,639
Matteo Droghetti retweeted
Replying to @DrMHofman @Uroweb
Spectacular LuTectomy case with PSA 340 and 5cm lymph node. Excellent PSA and imaging response with straightforward surgery and PSA undetectable at one year #eau23 – at Milan, Lombardy
1
12
1
53
3,474